TFE3 and renal carcinoma: Renal carcinoma with Xp11.2 translocation involving TFE3 gene fusion was first recognized as a distinct entity in 2004, and later in 2016, it was classified in the category of renal carcinomas with MiT gene translocations, alongside renal carcinoma with transcription factor B (TFB) gene fusion.